Envafolimab combined with chemotherapy in the treatment of combined small cell lung cancer: A case report

BACKGROUND: Combined small cell lung cancer (C-SCLC) is a special subtype of small cell lung cancer that is relatively rare, aggressive, and prone to early metastasis and has a poor prognosis. Currently, there are limited studies on C-SCLC, and there is no uniform standard treatment, especially for...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Mei-Hong, Li, Yan-Xia, Liu, Zhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979283/
https://www.ncbi.nlm.nih.gov/pubmed/36874434
http://dx.doi.org/10.12998/wjcc.v11.i5.1115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979283/
https://www.ncbi.nlm.nih.gov/pubmed/36874434
http://dx.doi.org/10.12998/wjcc.v11.i5.1115

Ejemplares similares